Myriad Genetics Q3 EPS Forecast Raised by Leerink Partnrs
Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) – Equities researchers at Leerink Partnrs raised their Q3 2025 earnings per share estimates for Myriad Genetics in a note issued to investors on Monday, April 21st. Leerink Partnrs analyst P. Souda now anticipates that the company will earn ($0.05) per share for the quarter, up from their […]
Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) – Equities researchers at Leerink Partnrs raised their Q3 2025 earnings per share estimates for Myriad Genetics in a note issued to investors on Monday, April 21st. Leerink Partnrs analyst P. Souda now anticipates that the company will earn ($0.05) per share for the quarter, up from their […]
